2012
DOI: 10.1128/jvi.07176-11
|View full text |Cite
|
Sign up to set email alerts
|

Increased Protection from Vaccinia Virus Infection in Mice Genetically Prone to Lymphoproliferative Disorders

Abstract: Mutations in the genes that encode Fas or Fas ligand (FasL) can result in poor restraints on lymphocyte activation and in increased susceptibility to autoimmune disorders. Because these mutations portend a continuously activated immune state, we hypothesized that they might in some cases confer resistance to infection. To examine this possibility, the immune response to, morbidity caused by, and clearance of vaccinia virus (VACV) Western Reserve was examined in 5- to 7-week-old Fas mutant ( lpr … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 68 publications
0
4
0
Order By: Relevance
“…Previous work has demonstrated that mice that have inactivating mutations in FAS (B6-lpr) are resistant to respiratory virus infections (41, 42). Therefore to address the role of perforin and TRAIL mediated cytotoxicity, we i.n.…”
Section: Resultsmentioning
confidence: 99%
“…Previous work has demonstrated that mice that have inactivating mutations in FAS (B6-lpr) are resistant to respiratory virus infections (41, 42). Therefore to address the role of perforin and TRAIL mediated cytotoxicity, we i.n.…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, Fas was dispensable for control of MCMV induced retinitis (Dix et al, 2004). In fact, lpr mice were more efficient at controlling vaccinia virus replication (Seedhom et al, 2012). Hence, although cytotoxic lymphocytes can use perforin/granzyme or Fas/FasL pathways to eliminate target cells, in vivo evidence indicates that Fas-FasL pathway has a modest role in cytolysis of virus-infected cells.…”
Section: Apoptotic Mechanisms In Anti-viral Immunitymentioning
confidence: 99%
“…VV peptides recognized by human or mouse CD8 + T cells have been identified (Moutaftsi et al, 2006; Tscharke et al, 2005; Tscharke et al, 2006), leading to definition of robust immunodominance hierarchies of CD8 + T cells responding to individual viral peptides (Flesch et al, 2010; Tscharke et al, 2005; Tscharke et al, 2006; Yewdell, 2006). Knockout mice have revealed gene products governing the strength of the VV-specific CD8 + T cell response ((Remakus and Sigal, 2011; Salek-Ardakani et al, 2009; Seedhom et al, 2012; Zhao and Croft, 2012), for examples).…”
Section: Introductionmentioning
confidence: 99%